APUS

APIMEDS PHARMACEUTICALS US I

APUS·03771D102·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

APUS (APIMEDS PHARMACEUTICALS US I) is held by 5 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($57,289), GEODE CAPITAL MANAGEMENT, LLC ($31,602), VANGUARD FIDUCIARY TRUST CO ($21,635). Net institutional sentiment: Mixed.

5
Holders
$135,555
Total Value
50% (4)
Consensus
2 buying - 2 selling
13F: Insider & Congress: Updated regularly
APUS

Smart Money Verdict

View all
Loading verdict
Held by 5 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders May 15, 2025 · Activists May 7, 2026 · Congress none

ActivistINInscobee Inc.16.7%May 7, 2026
ActivistAYAyrton Capital LLC10.0%Feb 11, 2026
InsiderKCKim ChristopherBuy $14KMay 14, 2025
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
63,654(-33.6%)$57,2890.0%-74.29%
0
Decreased
35,114(-12.3%)$31,6020.0%-73.96%
0
Unchanged
24,039$21,6350.0%-74.29%
0
New
15,993$14,3930.0%-48.89%
27
Increased
11,818(+182.3%)$10,6360.0%-61.91%
19
APUSAPUSAPIMEDS PHARMACEUTICALS US I

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used